Oncology Support
This category covers medicines used in cancer care, from hormone-blocking tablets to chemotherapy agents. They are part of a treatment plan led by a cancer specialist. Because these medicines belong to a specialist plan, the useful thing a catalogue page can do is explain what the classes are, not how they are used.

Methotrexate Tablets
2.5mg
Methotrexate 2.5mg tablets, used in the management of rheumatoid arthritis, psoriasis and Crohn's disease. A folic acid antagonist blocking dihydrofolate reductase.

Abiraterone Tablets
250mg
Abiraterone 250mg tablets, used in the management of prostate cancer. A CYP17A1 inhibitor that blocks androgen synthesis in the adrenal glands.

Lenalidomide Capsules
10mg
Lenalidomide 10mg hard capsules, used in the management of multiple myeloma and myelodysplastic syndromes. A thalidomide analogue and immunomodulator.
Key points
- These medicines belong inside a treatment plan led by a cancer specialist.
- Hormone-blocking tablets and chemotherapy agents work in fundamentally different ways and are not alternatives to each other.
- Monitoring for blood, liver and other effects is part of treatment rather than an add-on.
Classes and ingredients in this category
- Hormonal therapies such as anastrozole, tamoxifen and flutamide treat hormone-sensitive cancers.
- Chemotherapy agents like cyclophosphamide, chlorambucil and hydroxycarbamide act on dividing cancer cells.
Conditions it covers
These medicines are used for breast cancer, prostate cancer, multiple myeloma and chronic myeloid leukaemia. Tumour type, stage and receptor status decide what is appropriate, none of which can be inferred from a listing.


















